Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josep Vidal

Showing results (1-10 of 445) with videos related to

Pageof 45
Sort By:
Medicina Clinica|December 2, 2014
[Modulation of the incretin effect in the treatment of diabetes]Josep Vidal
Medicina Clinica|October 20, 2014
[Modulation of the incretin effect in the treatment of diabetes]Josep Vidal
European Endocrinology|June 21, 2018
Lixisenatide - A New Glucagon-like Peptide 1 Receptor Agonist in the Treatment of Type 2 DiabetesJosep Vidal
Atencion Primaria|April 3, 2024
[New information and communication technologies in primary and community care]Josep Vidal-Alaball
Current Atherosclerosis Reports|August 20, 2013
Diabetes remission following metabolic surgery: is GLP-1 the culprit?Josep Vidal, Amanda Jiménez
Medicina Clinica|July 16, 2024
[Has the first treatment of type2 diabetes mellitus changed?]Lilliam Flores, Josep Vidal
Medicina Clinica|June 9, 2006
[Leptin, obesity, and arterial hypertension]Josep Vidal Cortada, Antonio Coca
International Journal of Integrated Care|August 31, 2022
Asynchronous Remote Communication as a Tool for Care Management in Primary Care: A Rapid Review of the LiteratureAïna Fuster-Casanovas, Josep Vidal-Alaball
Enfermeria Clinica (English Edition)|February 28, 2022
Health social determinants in primary healthcare, coding and treatmentBerta Rodoreda Pallàs, Josep Vidal-Alaball
BMJ (Clinical Research Ed.)|May 22, 2010
Reduced serum vitamin B-12 in patients taking metforminJosep Vidal-Alaball, Christopher C Butler
Pageof 45

Showing results (1-10 of 445) with videos related to

Sort By:
Pageof 45
Medicina Clinica|December 2, 2014
[Modulation of the incretin effect in the treatment of diabetes]Josep Vidal
Medicina Clinica|October 20, 2014
[Modulation of the incretin effect in the treatment of diabetes]Josep Vidal
European Endocrinology|June 21, 2018
Lixisenatide - A New Glucagon-like Peptide 1 Receptor Agonist in the Treatment of Type 2 DiabetesJosep Vidal
Atencion Primaria|April 3, 2024
[New information and communication technologies in primary and community care]Josep Vidal-Alaball
Current Atherosclerosis Reports|August 20, 2013
Diabetes remission following metabolic surgery: is GLP-1 the culprit?Josep Vidal, Amanda Jiménez
Medicina Clinica|July 16, 2024
[Has the first treatment of type2 diabetes mellitus changed?]Lilliam Flores, Josep Vidal
Medicina Clinica|June 9, 2006
[Leptin, obesity, and arterial hypertension]Josep Vidal Cortada, Antonio Coca
International Journal of Integrated Care|August 31, 2022
Asynchronous Remote Communication as a Tool for Care Management in Primary Care: A Rapid Review of the LiteratureAïna Fuster-Casanovas, Josep Vidal-Alaball
Enfermeria Clinica (English Edition)|February 28, 2022
Health social determinants in primary healthcare, coding and treatmentBerta Rodoreda Pallàs, Josep Vidal-Alaball
BMJ (Clinical Research Ed.)|May 22, 2010
Reduced serum vitamin B-12 in patients taking metforminJosep Vidal-Alaball, Christopher C Butler
Pageof 45